Krystal Biotech, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 93.90%93.09%
EBT Margin 4,662.87%25.44%32.82%
EBIT Margin 4,576.07%-216.42%22.61%
EBITDA Margin 4,674.20%24.26%30.40%
Operating Margin 4,576.07%-216.42%22.61%
Net Margin 4,662.87%21.56%30.69%
FCF Margin 7,793.16%-198.43%39.56%
Efficiency
Inventory Average 16.75M
Assets Average 592.37M688.40M937.10M
Equity Average 557.90M650.44M862.51M
Invested Capital 593.58M522.23M778.64M946.38M
Asset Utilization Ratio 0.070.31
Leverage & Solvency
Interest Coverage Ratio -45.76
Equity Ratio 0.950.940.950.90
Times Interest Earned -45.76
Valuation
Enterprise Value 1,182.46M1,117.45M1,660.56M3,909.76M3,908.11M
Market Capitalization 1,182.46M1,555.55M2,039.73M4,441.94M4,505.63M
Return Ratios
Return on Sales 46.63%0.22%0.31%
Return on Capital Employed -0.26%-0.17%0.08%
Return on Invested Capital -0.14%0.07%
Return on Assets -0.24%0.02%0.10%
Return on Equity -0.25%0.02%0.10%